Intravascular Ultrasound-Guided Management of Angiographically Intermediate Non-Culprit Coronary Artery Lesions in Acute Coronary Syndrome
|
|
- Douglas Tyler Dickerson
- 5 years ago
- Views:
Transcription
1 Med. J. Cairo Univ., Vol. 85, No. 4, June: , Intravascular Ultrasound-Guided Management of Angiographically Intermediate Non-Culprit Coronary Artery Lesions in Acute Coronary Syndrome FAROUK M. FARES, M.D.; AKRAM M. ABD ELBARY, M.D.; AHMED H. MOWAF, M.D.; MOHAMED A. SHAWKY, M.D. and HELMY H. ELGHAWABY, M.D. The Department of Critical Care Medicine, Faculty of Medicine, Cairo University Abstract Background: The assessment of intermediate coronary lesions using coronary angiography is often challenging. The purpose of this study was to use an intravascular ultrasoundguided strategy to determine the anatomical significance of angiographically intermediate non-culprit coronary lesions to help in their management in the setting of ACS. Methods: We conducted an intravascular ultrasound studies on sixty one angiographically intermediate non-culprit coronary lesions in twenty eight patients with Non ST elevation ACS. Revascularization was recommended when percent area stenosis 70% Results: Minimal and maximal lumen diameters were significantly lower (p<0.001), MLA was significantly lower (p<0.001) and percent area stenosis was significantly higher in revascularization group (p<0.001). MLA & plaque burden are the main predictors for lesion anatomical significance with (p<0.001, OR=0.25, 95% CI= ) and ( p=0.011, OR=2.0, 95% CI= ) respectively. Conclusions: MLA & plaque burden are the main predictors for lesion anatomical significance. Key Words: Intermediate lesions IVUS: Intravascular ultrasound MLA: Minimal lumen area ACS: Acute coronary syndrome. Introduction ACUTE coronary syndromes may frequently arise from lesions with only mild to moderate stenosis since these lesions may be more common than severe obstructive lesions [1-5]. Conventional angiography is the gold standard in clinical practice for diagnosing atherosclerotic compromise of the coronary artery tree. However, coronary angiography has several known limitations, including a lack of correlation between the Correspondence to: Dr. Farouk M. Fares, The Department of Critical Care Medicine, Faculty of Medicine, Cairo University percentage of stenosis and the lesion s physiologic importance and considerable inter-observer variability in classifying the lesion s severity [6-8]. IVUS has been used extensively for assessment of intermediate coronary lesions to demonstrate functional significance (the induction of ischemia) together with FFR and other non-invasive measures [9]. An IVUS-measured minimal luminal area (MLA) of <4.0mm 2 has been used as a marker of severe coronary artery stenosis, which correlates well with the findings of other methods for diagnosing myocardial ischemia, including singlephoton emission computed tomography (SPECT) [10], doppler wire studies [11], and pressure wire measurement [12]. The clinical importance of this criterion has been confirmed by a study showing that deferral of revascularization is safe for patients with an MLA of >4.0mm 2 [13]. Also, IVUS can guide therapeutic strategy in lesions requiring percutaneous coronary intervention (PCI), and assess stent deployment [14]. Aim of work: The use an intravascular ultrasound-guided strategy to determine the anatomical significance of angiographically intermediate non-culprit coronary lesions to help in their management in the setting of ACS. Patients and Methods An observational cross-sectional study was conducted at Critical Care Department, Cairo University between January 2013 and December Inclusion criteria: Twenty eight patients with the diagnosis of unstable angina and non-st- 1335
2 1336 Intravascular Ultrasound-Guided Management of Angiographically Intermediate elevation myocardial infarction had sixty one angiographically-intermediate non-culprit coronary lesions either in culprit or non-culprit vessels. According to the American College of Cardiology and the American Heart Association, intermediate stenosis was defined as having a diameter of 40% and <70%, as measured by quantitative coronary angiography (QCA) [15]. IVUS had been used to further define the severity of these lesions then management either conservatively or by percutaneous coronary intervention (PCI). All patients had clinical evidence of myocardial ischemia in the territory of the culprit vessel including ECG changes, perfusion defects on technetium 99m sestamibi (MIBI) single photon emission computed tomography (SPECT) and regional wall motion abnormalities on echocardiograms. Exclusion criteria: Patients were excluded if they had an ST-elevation acute myocardial infarction, any contraindication to anticoagulation, renal impairment or previous coronary artery bypass grafting (CABG). Diagnostic methods: The diagnostic angiograms were obtained using Digital Imaging and Communications in Medicine (DICOM)-compatible digital systems (Siemens AG model No , Germany & Philips CV20, Netherland). Prior to beginning the IVUS studies, patients were given 10,000 U of unfractionated heparin for systemic anticoagulation. IVUS was performed using conventional 6Fr guiding catheters and a 0.014mm guidewire was positioned distally. IVUS catheters of 40MHz (Atlantis; Boston Scientific Corp., Natick, Massachusetts) were pulled back automatically at a constant speed of 0.5mm/second. The measurements were performed according to the guidelines of the American College of Cardiology for the acquisition, measurement and reporting of IVUS studies [16]. The following parameters were included in the IVUS analyses: Minimal lumen area (MLA), external elastic membrane (EEM) cross sectional area, plaque area, percent area stenosis, remodeling index, minimal and maximal lumen diameters, proximal and distal reference diameter. Plaque burden is calculated as plaque area divided by the EEM cross sectional area. If EEM area increases during atheroma development, the process is termed positive remodeling. If the EEM decreases, the process is termed negative or constrictive remodeling. An index that describes the magnitude and direction of remodeling is expressed as: Lesion EEM CSA/reference EEM CSA. If the lesion EEM area is greater than the reference EEM area, positive remodeling has occurred, and the index will be >1.0. If the lesion EEM area is smaller than the reference EEM area, negative remodeling has occurred, and the index will be <1.0 [17]. Statistical analysis: Pre-coded data was entered on the computer using "Microsoft Office Excel Software" program (2010) for windows. Data was then transferred to the Statistical Package of Social Science Software program, version 21 (SPSS) to be statistically analyzed. Data was summarized using mean, standard deviation, median and inter quartile range for quantitative variables and frequency and percentage for qualitative ones. Comparison between groups was performed using independent sample t-test or one way ANOVA with Tukey s post hoc test for quantitative variables and Chi square or Fisher s exact test for qualitative ones. Pearson correlation coefficients were calculated to get the association between different quantitative variables. Logistic regression analysis was performed to explore the significant predictors of revascularization. p-values less than 0.05 were considered statistically significant, and less than 0.01 were considered highly significant. Results Twenty eight patients presented by NSTEMI ACS with the following demographic & clinical data as in Table (1). Table (1): Demographic and clinical data of study patients. Range Mean ± SD Age (years) ±9.1 Body mass index ±2.9 TIMI risk score ± 1.4 Laboratory results: Hemoglobin (gm%) ± 1.7 Creatinine (mg/dl) ±0.2 Cholesterol (mg/dl) ±30.4 Frequency Percentage (n=28) (%) Gender: Male Female Risk factors: Smoking Diabetes Mellitus Hypertension Dyslipidemia ve Family history History of CAD: Previous MI Previous PCI Clinical diagnosis: Unstable angina NSTEMI
3 Farouk M. Fares, et al Angiographic data: Shown in Table (2) & Fig. (1): Table (2): Number of vessels diseased. Number of patients Percentage Single vessel disease Two vessel disease Multi-vessel disease lesions Visual assessment Significant Intermediate Non-significant lesions=31 lesions=61 lesions=11 7.1% IVUS 60.8% 32.1% Medical treatment Group I=34 Revascularization Group II=27 Fig. (3): Distribution and fate of all lesions. Single vessel disease 55.7% Multi-vessel disease Two vessel disease Fig. (1): Number of vessels diseased. Coronary angiography showed 103 total lesions divided by visual assessment into: Thirty one significant lesions (30.1%) showed more than 70% stenosis. Sixty one intermediate lesions (59.2%) with 40-70% stenosis. Eleven non-significant lesions (10.7%) with less than 40% stenosis. Fifty three (86.8%) of the 61 intermediate lesions were located at the proximal and midportions of the artery. According to the adopted IVUS criteria (percent area stenosis >70%), the lesions were divided into two groups; group I including 34 lesions (55.7%) for deferral of revascularization and group II including 27 lesions (44.3%) for revascularization. 44.3% Group II lesions were more severe, as indicated by a higher percentage of luminal area stenosis (p<0.001) and lower minimal lumen area (p<0.001) detected by IVUS. Also, maximal and minimal lumen diameters were significantly lower in revascularization group than medical treatment group (p<0.001). Mean lesion MLA Mean percent stenosis p< ± ± ± 1.56 p<0.001 Medical treatment Revascularization Fig. (4): Lesion MLA in both groups ± Revascularization Medical treatment Fig. (2): Grouping according to IVUS measures Medical treatment Revascularization Fig. (5): Percent area stenosis in both groups.
4 1338 Intravascular Ultrasound-Guided Management of Angiographically Intermediate Most of the lesions were eccentric and showed negative remodeling [34 lesions (55.7%)] Percentage 44.3 Negative remodelling Positive remodelling Fig. (6): Remodeling of intermediate lesions. Further analysis of IVUS data by Backward stepwise regression model showed that MLA & plaque burden are the main predictors for lesion anatomical significance with (p<0.001, OR=0.25, 95% CI= ) and (p=0.011, OR=2.0, 95% CI= ) respectively. Discussion Assessment of a coronary lesion with intermediate severity continues to be a challenge. It might be tempting to treat all suspect lesions with implantation of a stent. However, there are still procedural complications associated with angioplasty, the inherent risk of restenosis, and late stent thrombosis [18,19]. Although it is preferable to have objective evidence of myocardial ischemia before proceeding with percutaneous coronary revascularization, this is not always feasible or completely reliable. All measures of noninvasive assessment of myocardial ischemia are compared with the presence of a focal stenosis >50% diameter. This cutoff is based on animal studies and human clinical correlations that demonstrate functional significance (the induction of ischemia) with the anatomic presence of a 50% diameter stenosis [9]. An important finding in our study was that most of lesions (49.2%) were located in the proximal segments of the examined arteries. Numerous pathological, angiographic, and imaging studies have shown a proximal predisposition of thin capped fibro-atheroma, acute occlusions, or plaque ruptures [20-25]. This tendency of advanced plaques to develop preferentially in these locations has been explained by the low shear stress conditions generated in areas with tortuosity or many branches. Low shear stress may induce the migration of lipid and monocytes into the vessel wall leading to the progression of the lesion towards a plaque with high risk of rupture [26]. The decision to intervene on a lesion is frequently made in the catheterization laboratory based on the visual estimation of the lesion s severity. Lesions with more than 70% stenosis on visual quantification are usually considered hemodynamically significant and submitted to intervention. However, data from pressure wire evaluation of lesions with less than 70% compromise of luminal diameter have shown that they are also frequently associated with impaired flow reserve and myocardial ischemia [27,28]. Moreover, previous IVUS studies have demonstrated the correlation between a MLA <4.0mm 2 and decreased fractional flow reserve [29], while a MLA 4.0mm 2 was correlated with a preserved fractional flow reserve and favorable outcomes with deferral of invasive intervention [13]. In the present study, 10% of the lesions diagnosed as moderate by conventional angiography had, in fact, severe stenosis by the adopted IVUS criterion (percent area stenosis >70%). The most obvious finding revealed from the analysis of our data is that minimal lumen area (MLA) & plaque burden were the main predictors for lesion significance for revascularization. These results are in agreement with those obtained by Koo et al. [20] which showed that minimal lumen area was the main determinant of functionally significant stenosis. Furthermore, Kang et al. [30] compared quantitative coronary angiography and intravascular ultrasound (IVUS) with stress myocardial singlephoton emission computed tomography (SPECT). Independent determinants for a positive SPECT were in-segment angiographic diameter stenosis & in-segment IVUS-MLA. Conclusion: Our study shows that intravascular ultrasound is a helpful tool in accurately assessing the degree of stenosis in the coronary lesions that appear angiographically intermediate in patients with ACS. Additionally, MLA & plaque burden are the main predictors for lesion anatomical significance. References 1- AMBROSE J.A., TANNENBAUM M.A., ALEXOPOU- LOS D., et al.: Angiographic progression of coronary artery disease and the development of myocardial infarction. J. Am. Coll. Cardiol., 12: 56-62, 1988.
5 Farouk M. Fares, et al LITTLE W.C., CONSTANTINESCU M., APPLEGATE R.J., et al.: Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mildto-moderate coronary artery disease? Circulation, 78: , GIROUD D., LI J.M., URBAN P., et al.: Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am. J. Cardiol., 69: , ALDERMAN E.L., CORLEY S.D., FISHER L.D., et al.: Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). J. Am. Coll. Cardiol., 22: , FALK E., SHAH P.K. and FUSTER V.: Coronary plaque disruption. Circulation, 92: , WHITE C.W., WRIGHT C.B., DOTY D.B., et al.: Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N. Engl. J. Med., 310: , ZIR L.M., MILLER S.W., DINSMORE R.E., et al.: Interobserver variability in coronary angiography. Circulation, 53: , DETRE K.M., WRIGHT E., MURPHY M.L. and TAKA- RO T.: Observer agreement in evaluating coronary angiograms. Circulation, 52: , GOULD K.L., LIPSCOMB K. and HAMILTON G.W.: Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am. J. Cardiol., 33: 87-94, NISHIOKA T., AMANULLAH A.M., LUO H., et al.: Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity: Comparison with stress myocardial perfusion imaging. J. Am. Coll. Cardiol., 33: , ABIZAID A., MINTZ G.S., PICHARD A.D., et al.: Clinical, intravascular ultrasound, and quantitative angiographic determinants of the coronary flow reserve before and aft er percutaneous transluminal coronary angioplasty. Am. J. Cardiol., 82: , TAKAGI A., TSURUMI Y., ISHII Y., et al.: Clinical potential of intravascular ultrasound for physiological assessment of coronary stenosis: Relationship between quantitative ultrasound tomography and pressure-derived fractional flow reserve. Circulation, 100: , ABIZAID A.S., MINTZ G.S., MEHRAN R., et al.: Longterm follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings: Importance of lumen dimensions. Circulation, 100: , MICHAEL C. McDANIEL, PARHAM ESHTEHARDI, FADI J. SAWAYA, et al.: Contemporary Clinical Applications of Coronary Intravascular Ultrasound. J. Am. Coll. Cardiol. Intv., 4: , SMITH S.C. Jr, DOVE J.T., JACOBS A.K., et al.: ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines) Executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J. Am. Coll. Cardiol., 37: , MINTZ G.S., NISSEN S.E., ANDERSON W.D., et al.: American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J. Am. Coll. Cardiol., 37: , SCHOENHAGEN P., ZIADA K.M., KAPADIA S.R., et al.: Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: An intravascular ultrasound study. Circulation, 101: , STONE G.W., ELLIS S.G., COX D.A., et al.: One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation, 109: , MOSES J.W., LEON M.B., POPMA J.J., et al.: Sirolimuseluting stents versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med., 349: , BON-KWON KOO, HYOUNG-MO YANG, JUN- HYUNG DOH, et al.: Optimal Intravascular Ultrasound Criteria and Their Accuracy for Defining the Functional Significance of Intermediate Coronary Stenoses of Different Locations. JACC: Cardiovascular interventions, Vol. 4, No. 7, : , MARLOS R. FERNANDES, GUILHERME V. SILVA, ADRIANO CAIXETA, et al. Assessing Intermediate Coronary Lesions: Angiographic Prediction of Lesion Severity on Intravascular Ultrasound. Journal of Invasive Cardiology, Volume 19 (10): 412-6, CHERUVU P.K., FINN A.V., GARDNER C., et al.: Frequency and distribution of thincap fibroatheroma and ruptured plaques in human coronary arteries: A pathologic study. J. Am. Coll. Cardiol., 50: 940-9, KUME T., OKURA H., YAMADA R., et al.: Frequency and spatial distribution of thin-cap fibroatheroma assessed by 3-vessel intravascular ultrasound and optical coherence tomography: an ex vivo validation and an initial in vivo feasibility study. Circ. J., 73: , HONG M.K., MINTZ G.S., LEE C.W., et al.: The site of plaque rupture in native coronary arteries: A three-vessel intravascular ultrasound analysis. J. Am. Coll. Cardiol., 46: 261-5, ANDO H., AMANO T., MATSUBARA T., et al.: Comparison of tissue characteristics between acute coronary syndrome and stable angina pectoris. An integrated backscatter intravascular ultrasound analysis of culprit and nonculprit lesions. Circ. J., 75: , CUNNINGHAM K.S. and GOTLIEB A.I.: The role of shear stress in the pathogenesis of atherosclerosis. Lab. Invest, 85: 9-23, WEIDEMANN F., JUNG P., HOYER C., et al.: Assessment of the contractile reserve in patients with intermediate coronary lesions: A strain rate imaging study validated by invasive myoc ardia l fra ctional flow reserve. Eur. Heart J., 28: , 2007.
6 1340 Intravascular Ultrasound-Guided Management of Angiographically Intermediate 28- HACKER M., RIEBER J., SCHMID R., et al.: Comparison of Tc-99m sestamibi SPECT with fractional flow reserve in patients with intermediate coronary artery stenoses. J. Nucl. Cardiol., 12: , BRIGUORI C., ANZUINI A., AIROLDI F., et al.: Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve. Am. J. Cardiol., 87: , KANG S.J., CHO Y.R., PARK G.M., et al.: Predictors for functionally significant in-stent restenosis: An integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging. JCMG. Nov. 6 (11): , 2013.
New Insight about FFR and IVUS MLA
New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR
More informationCulprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome
Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,
More informationEvaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013
Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Disclosures Consultant- St Jude Medical Boston Scientific Speaker- Volcano Corporation Heart
More informationDeclaration of conflict of interest. Nothing to disclose
Declaration of conflict of interest Nothing to disclose Hong-Seok Lim, Seung-Jea Tahk, Hyoung-Mo Yang, Jin-Woo Kim, Kyoung- Woo Seo, Byoung-Joo Choi, So-Yeon Choi, Myeong-Ho Yoon, Gyo-Seung Hwang, Joon-Han
More informationAnatomy is Destiny, But Physiology is Here Today
Published on Journal of Invasive Cardiology (http://www.invasivecardiology.com) September, 2010 [1] Anatomy is Destiny, But Physiology is Here Today Thu, 9/9/10-10:54am 0 Comments Section: Commentary Issue
More informationBetween Coronary Angiography and Fractional Flow Reserve
Visual-Functional Mismatch Between Coronary Angiography and Fractional Flow Reserve Seung-Jung Park, MD., PhD. University of Ulsan, College of Medicine Asan Medical Center, Seoul, Korea Visual - Functional
More informationGary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function
Gary S. Mintz,, MD IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Important IVUS Observations: Remodeling Originally used (first by Glagov) ) to explain atherosclerosis
More informationThe Site of Plaque Rupture in Native Coronary Arteries
Journal of the American College of Cardiology Vol. 46, No. 2, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.03.067
More informationPlaque Shift vs. Carina Shift Prevalence and Implication
TCTAP 2013 Fellowship Course Left Main and Bifurcation PCI: Bifurcation PCI Plaque Shift vs. Carina Shift Prevalence and Implication Soo-Jin Kang, MD., PhD. Department of Cardiology, University of Ulsan
More informationFIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study
Journal of the American College of Cardiology Vol. 61, No. 9, 2013 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.12.012
More informationIVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea
IVUS Analysis Myeong-Ki Hong, MD, PhD Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Intimal disease (plaque) is dense and will appear white Media is made of
More informationSo-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea
So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea Anatomical vs Functional Significance? Coronary Angiogram Treadmill Test Tc-99m-MIBI SPECT MDCT Coronary Angiogram
More informationIntravascular ultrasound-based analysis of factors affecting minimum lumen area in coronary artery intermediate lesions
Journal of Geriatric Cardiology (2016) 13: 169 174 2016 JGC All rights reserved; www.jgc301.com Research Article Open Access Intravascular ultrasound-based analysis of factors affecting minimum lumen area
More informationCardiovascular Research Foundation and Columbia University Medical Center, New York.
Virtual Histology Intravascular Ultrasound Analysis of Non-culprit Attenuated Plaques Detected by Grayscale Intravascular Ultrasound in Patients with Acute Coronary Syndromes Xiaofan Wu, Akiko Maehara,
More informationIntegrated Use of IVUS and FFR for LM Stenting
Integrated Use of IVUS and FFR for LM Stenting Gary S. Mintz, MD Cardiovascular Research Foundation Four studies have highlighted the inaccuracy of angiography in the assessment of LMCA disease Fisher
More informationSide Branch Occlusion
Side Branch Occlusion Mechanism, Outcome, and How to avoid it From COBIS II Registry Hyeon-Cheol Gwon Cardiac&Vascular Center, Samsung Medical Center Sungkyunkwan University School of Medicine SB occlusion
More informationUpgrade of Recommendation
Challenges in LM PCI Decision-making process for stenting Young-Hak Kim, MD, PhD, Heart Institute, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea Upgrade of Recommendation for
More informationFFR-guided Jailed Side Branch Intervention
FFR-guided Jailed Side Branch Intervention - Pressure wire in Bifurcation lesions - Bon-Kwon Koo, MD, PhD Seoul National University Hospital, Seoul, Korea Bifurcation Lesions Bifurcation Lesions Still
More informationValidation of Minimal Luminal Area Measured by Intravascular Ultrasound for Assessment of Functionally Significant Coronary Stenosis
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 6, 2011 2011 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.02.013 Validation
More informationFFR and intravascular imaging, which of which?
FFR and intravascular imaging, which of which? Ayman Khairy MD, PhD, FESC Associate professor of Cardiovascular Medicine Vice Director of Assiut University Hospitals Assiut, Egypt Diagnostic assessment
More informationPCI for Left Anterior Descending Artery Ostial Stenosis
PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary
More informationFFR Incorporating & Expanding it s use in Clinical Practice
FFR Incorporating & Expanding it s use in Clinical Practice Suleiman Kharabsheh, MD Consultant Invasive Cardiology Assistant professor, Alfaisal Univ. KFHI - KFSHRC Concept of FFR Maximum flow down a vessel
More informationFractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center
Fractional Flow Reserve: Basics, FAME 1, FAME 2 William F. Fearon, MD Associate Professor Stanford University Medical Center Conflict of Interest Advisory Board for HeartFlow Research grant from St. Jude
More informationEffect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators
More informationCASE from South Korea
CASE from South Korea Bon-Kwon Koo, MD, PhD, Seoul, Korea Outpatient clinic of a non-interventional cardiologist F/56 Chief complaint: Angina with recent aggravation, CCS II~III Brief history: # Stroke
More informationThe PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque
The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively
More informationDiabetes and Occult Coronary Artery Disease
Diabetes and Occult Coronary Artery Disease Mun K. Hong, MD, FACC, FSCAI Director, Cardiac Catheterization Laboratory & Interventional Cardiology St. Luke s-roosevelt Hospital Center New York, New York
More informationPatient referral for elective coronary angiography: challenging the current strategy
Patient referral for elective coronary angiography: challenging the current strategy M. Santos, A. Ferreira, A. P. Sousa, J. Brito, R. Calé, L. Raposo, P. Gonçalves, R. Teles, M. Almeida, M. Mendes Cardiology
More informationIVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD.
Left Main and Bifurcation Summit IVUS-Guided d Provisional i Stenting: ti Plaque or Carina Shift Soo-Jin Kang, MD., PhD. Department of Cardiology, University of Ulsan College of Medicine Asan Medical Center,
More informationCan IVUS Define Plaque Features that Impact Patient Care?
Can IVUS Define Plaque Features that Impact Patient Care? A Pichard L Satler, K Kent, R Waksman, W Suddath, N Bernardo, N Weissman, M Angelo, D Harrington, J Lindsay, J Panza. Washington Hospital Center
More informationΚλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE
Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE Conflict of interest None to declare While IVUS is the most used intravascular
More informationTitle for Paragraph Format Slide
Title for Paragraph Format Slide Presentation Title: Month Date, Year Atherosclerosis A Spectrum of Disease: February 12, 2015 Richard Cameron Padgett, MD Executive Medical Director, OHVI Pt RB Age 38
More information2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center
2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium Does Lt Late Cth Catch up Exist Eiti in DES? : Quantitative Coronary Angiography Analysis Kyung Woo Park, MD Cardiovascular
More informationPrognostic Value of Gated Myocardial Perfusion SPECT
Current Use of IVUS & FFR George D. Dangas, MD, PhD, FACC, FSCAI Professor of Medicine Mount Sinai School of Medicine Prognostic Value of Gated Myocardial Perfusion SPECT 0.6% / year, Cardiac Death and
More informationAdded Value of Invasive Coronary Imaging for Plaque Rupture and Erosion
Assessment of Coronary Plaque Rupture and Erosion Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Yukio Ozaki, MD, PhD, FACC, FESC Cardiology Dept., Fujita Health Univ. Toyoake,
More informationTHE COMPLEX RELATION BETWEEN VULNERABILITY AND ISCHEMIA a paradigm shift
THE COMPLEX RELATION BETWEEN VULNERABILITY AND ISCHEMIA a paradigm shift Angioplasty Summit TCT ASIA Seoul, Korea, april 23rd, 2008 Nico H. J. Pijls, MD, PhD Catharina Hospital, Eindhoven, The Netherlands
More informationFractional Flow Reserve. A physiological approach to guide complex interventions
Fractional Flow Reserve A physiological approach to guide complex interventions What is FFR? Fractional Flow Reserve (FFR) is a lesion specific, physiological index determining the hemodynamic severity
More informationPremier Health Plan considers Intravascular Ultrasound (IVUS) for Coronary Vessels medically necessary for the following indications:
Premier Health Plan POLICY AND PROCEDURE MANUAL MP.091.PH - Intravascular Ultrasound for Coronary Vessels This policy applies to the following lines of business: Premier Commercial Premier Employee Premier
More informationImaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging
Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Gary S. Mintz,, MD Cardiovascular Research Foundation New York, NY Today, in reality, almost everything
More informationNoninvasive Fractional Flow Reserve from Coronary CT Angiography
2016 KSC Annual Spring Scientific Conference Noninvasive Fractional Flow Reserve from Coronary CT Angiography Bon-Kwon Koo, MD, PhD, Seoul, Korea Why the hemodynamics for coronary artery disease? Twinlifemarketing.com.au
More informationCan We Safely Defer PCI. Yes, already proven
Can We Safely Defer PCI Just Based on FFR>0.80? Yes, already proven Seung-Jung Park, MD., PhD. Professor of Medicine, University of Ulsan, College of Medicine Heart Institute, Asan Medical Center, Seoul,
More informationWhat is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?
What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko,
More informationQuick guide. Core. precision guided therapy system
Quick guide Core precision guided therapy system The Philips Volcano imaging system should only be operated by trained personnel. The following information is presented for your convenience and is not
More informationDiagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed TOmographic Angiography: The DeFACTO Study
Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed TOmographic Angiography: The DeFACTO Study James K. Min 1 ; Jonathon Leipsic 2 ; Michael J. Pencina 3 ; Daniel S. Berman 1 ; Bon-Kwon
More informationDESolve NX Trial Clinical and Imaging Results
DESolve NX Trial Clinical and Imaging Results Alexandre Abizaid, MD, PhD, Instituto Dante Pazzanese, Sao Paulo, Brazil On behalf of the DESolve Nx Trial Investigators Please refer to the TCT2014 App or
More information대한심장학회춘계학술대회 Satellite Symposium
대한심장학회춘계학술대회 Satellite Symposium Coronary Plaque Regression and Compositional Changes by Lipid-Lowering Therapy: IVUS Substudy in Livalo (Pitavastatin) in Acute Myocardial Infarction Study (LAMIS) Livalo
More informationAssessment of plaque morphology by OCT in patients with ACS
Assessment of plaque morphology by OCT in patients with ACS Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Unstable plaque Intima Lipid core Plaque rupture and coronary events
More informationCOURAGE to Leave Diseased Arteries Alone
COURAGE to Leave Diseased Arteries Alone Spencer King MD MACC, FSCAI St. Joseph s s Heart and Vascular Institute Professor of Medicine Emeritus Emory Univ. Atlanta, USA Conflict: I am an Interventionalist
More informationAngiographic long-term results after implantation of the paclitaxel-eluting coronary stent coroflex please : Data under real-world conditions
244 U. Gerk, B. Leithäuser, U. Schäfer, F. Jung, J.-W. Park Applied Cardiopulmonary Pathophysiology 14: 244-249, 2010 Angiographic long-term results after implantation of the paclitaxel-eluting coronary
More informationImportant LM bifurcation studies update
8 th European Bifurcation Club 12-13 October 2012 - Barcelona Important LM bifurcation studies update I Sheiban E-mail: isheiban@yahoo.com Unprotected LM Percutaneous Revascularization What is important
More informationFFR in Left Main Disease
FFR in Left Main Disease William F. Fearon, MD Associate Professor of Medicine Director, Interventional Cardiology Stanford University Medical Center Why FFR instead of IVUS? Physiologic versus anatomic
More informationA Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience
A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience Juan F. Granada, MD Medical Director, Skirball Center for Cardiovascular Research The Cardiovascular
More informationImpact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease
Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,
More informationEAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers
EAE Teaching Course Magnetic Resonance Imaging Competitive or Complementary? Sofia, Bulgaria, 5-7 April 2012 F.E. Rademakers Complementary? Of Course N Engl J Med 2012;366:54-63 Clinical relevance Treatment
More informationFFR and IVUS Guided DES Implantation in Long Diffuse Lesions
FFR and IVUS Guided DES Implantation in Long Diffuse Lesions Can We Reach Optimal DES Expansion With Conventional Stent Delivery System in Long Diffuse Lesion? Seung-Jea Tahk, MD., PhD. Ajou University
More informationΣεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική
ΕΛΛΗΝΙΚΗΚΑΡΔΙΟΛΟΓΙΚΗΕΤΑΙΡΕΙΑ Σεμινάριο Ομάδων Εργασίας 2011 Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική GUIDELINES ON MYOCARDIAL
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationJACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 7, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 7, 2011 2011 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.03.013 Optimal Intravascular
More informationShould we be using fractional flow reserve more routinely to select stable coronary patients for percutaneous coronary intervention?
REVIEW C URRENT OPINION Should we be using fractional flow reserve more routinely to select stable coronary patients for percutaneous coronary intervention? Seung-Jung Park and Jung-Min Ahn Purpose of
More informationLeft Main Intervention: Where are we in 2015?
Left Main Intervention: Where are we in 2015? David A. Cox, MD FSCAI Director, Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown, PA Fall Fellows Course Laa
More informationThree-vessel fractional flow reserve measurement for predicting clinical prognosis in patients with coronary artery disease
Editorial Three-vessel fractional flow reserve measurement for predicting clinical prognosis in patients with coronary artery disease Takashi Kubo, Hiroki Emori, Yosuke Katayama, Kosei Terada Department
More informationFractional Flow Reserve and instantaneous wave -free Ratio. Λάμπρος Κ. Μόσιαλος Επεμβατικός Καρδιολόγος ΓΝ Παπαγεωργίου
Fractional Flow Reserve and instantaneous wave -free Ratio Λάμπρος Κ. Μόσιαλος Επεμβατικός Καρδιολόγος ΓΝ Παπαγεωργίου DISCLOSURES There are no financial conflicts of interest relevant to this presentation
More informationJose Mª de la Torre Hernandez, MD, PhD, FESC. Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander. SPAIN
Validation and application of IVUS-MLA in LMCA disease Jose Mª de la Torre Hernandez, MD, PhD, FESC Interventional Cardiology Dpt Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander.
More informationJournal of the American College of Cardiology Vol. 46, No. 5, by the American College of Cardiology Foundation ISSN /05/$30.
Journal of the American College of Cardiology Vol. 46, No. 5, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.06.009
More informationUnprotected LM intervention
Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline
More informationPercutaneous Coronary Interventions Without On-site Cardiac Surgery
Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European
More informationIntervention: How and to which extent is technology helping us?
Cardiological Society of India Congress 12th February 2016 Chennai, India Intervention: How and to which extent is technology helping us? SIMONE BISCAGLIA MD CARDIOVASCULAR INSTITUTE, FERRARA, ITALY Introduction
More informationThe PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque
The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively
More informationBenefit of Performing PCI Based on FFR
Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationFractional Flow Reserve: Review of the latest data
Fractional Flow Reserve: Review of the latest data Michalis Hamilos, MD, PhD, FESC University Hospital of Heraklion Fractional Flow Reserve (FFR) Coronary angiography does not always tell the truth Most
More informationPCIs on Intermediate Lesions NCDR Cath-PCI Registry
Practical Application Of Coronary Physiology in The Cath Lab Talal T Attar, MD, MBA, FACC PCIs on Intermediate Lesions NCDR Cath-PCI Registry Fraction of stenoses 50-70% treated with PCI without further
More informationINSIDE INFORMATION YOU CAN T IGNORE
INSIDE INFORMATION YOU CAN T IGNORE Volcano, the Volcano logo and SyncVision are registered trademarks of Volcano Corporation. All other trademarks set-forth are properties of their respective owners.
More informationIVUS Virtual Histology. Listening through Walls D. Geoffrey Vince, PhD The Cleveland Clinic Foundation
IVUS Virtual Histology Listening through Walls D. Geoffrey Vince, PhD Disclosure VH is licenced to Volcano Therapeutics Grant funding from Pfizer, Inc. Grant funding from Boston-Scientific Most Myocardial
More informationInvasive Versus Noninvasive Evaluation of Coronary Artery Disease
JACC: CARDIOVASCULAR IMAGING VOL. 1, NO. 2, 2008 2008 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/08/$34.00 PUBLISHED BY ELSEVIER INC. DOI:10.1016/j.jcmg.2007.12.003 Invasive Versus
More informationIntravascular Ultrasound
May 2008 Beth Israel Deaconess Medical Center Harvard Medical School Intravascular Ultrasound Matthew Altman, HMS III Gillian Lieberman, MD BIDMC Department of Radiology Presentation Overview 1. Patient
More informationImaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD
Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference
More informationIntegrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes. Gary S. Mintz, MD Cardiovascular Research Foundation
Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes Gary S. Mintz, MD Cardiovascular Research Foundation COURAGE Nuclear Substudy (n=314) Death/MI according the residual ischemia (SPECT)
More informationCoronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital
Coronary Artery Imaging Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital Larger array : cover scan area Detector size : spatial resolution Rotation speed : scan time Retrospective
More informationLessons learned From The National PCI Registry
Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients
More informationPCI for In-Stent Restenosis. CardioVascular Research Foundation
PCI for In-Stent Restenosis ISR of BMS Patterns of In-Stent Restenosis Pattern I : Focal Type IA: Articulation / Gap Type IB: Marginal Type IC: Focal body Type ID: Multifocal Pattern II,III,IV : Diffuse
More informationClinical Investigations
Clinical Investigations Clinical Outcomes for Single Stent and Multiple Stents in Contemporary Practice Qiao Shu Bin, MD; Liu Sheng Wen, MD; Xu Bo, BS; Chen Jue, MD; Liu Hai Bo, MD; Yang Yue Jin, MD; Chen
More informationTCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI
Indian TUXEDO Trial In Medically Treated Diabetics Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Executive Director and Dean Escorts Heart Institute & Medical Research Center and Fortis Hospitals, New Delhi
More informationInvasive Coronary Imaging Modalities for Vulnerable Plaque Detection
Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Greyscale IVUS studies have shown Plaque ruptures do not occur randomly
More informationLM stenting - Cypher
LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with
More informationSirolimus-Eluting Stents for Treatment of In-Stent Restenosis
Clinical Investigation Alfonso Medina, MD José Suárez de Lezo, MD Manuel Pan, MD Antonio Delgado, MD José Segura, MD Djordje Pavlovic, MD Francisco Melián, MD Miguel Romero, MD Federico Segura, MD Enrique
More informationMULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION
MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides Euromedica Kyanous Stavros, Thessaloniki.
More informationAtypical pain and normal exercise test
Atypical pain and normal exercise test F. Mut, M. Beretta Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Clinical history 67-year old male with several coronary risk factors. Atypical
More informationFFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators
FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators Heart Vascular Stroke Institute, Samsung Medical Center, Seoul, Republic of
More informationPCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France
PCI for Left Main Coronary Artery Stenosis Jean Fajadet Clinique Pasteur, Toulouse, France Athens, October 19, 2018 Left Main Coronary Artery Disease Significant unprotected left main coronary artery disease
More informationThree-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G.
Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G. Ellis MD Dean J. Kereiakes MD and Gregg W. Stone MD for the ABSORB
More informationWhat do the guidelines say?
Percutaneous coronary intervention in 3-vessel disease and main stem What do the guidelines say? Nothing to disclose Dariusz Dudek Institute of Cardiology, Jagiellonian University Krakow, Poland The European
More informationAbstract Background: Methods: Results: Conclusions:
Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li
More informationPost PCI functional testing and imaging: case based lessons from FFR React
Post PCI functional testing and imaging: case based lessons from FFR React Joost Daemen, MD, PhD, FESC Optics in Cardiology 2018 April 21st, 2018 10.15 10.30h Disclosure Statement of Financial Interest
More informationLeft Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD
Left Main PCI Integrated Use of IVUS and FFR Seung-Jung Park, MD, PhD Professor of Medicine, University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea Efficacy of Left
More informationClinical case in perspective. Cases from Poland
Clinical case in perspective Cases from Poland Assoc. Prof. Jacek Legutko, MD, PhD President-Elect of the Association for Percutaneous Cardiovascular Interventions of the Polish Cardiac Society Institute
More informationOriginal Article. Korean Circulation Journal
Original Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Clinical Outcomes in Patients with Intermediate Coronary Stenoses: MINIATURE Investigators (Korea MultIceNter TrIal
More informationClinical Trial Synopsis TL-OPI-516, NCT#
Clinical Trial Synopsis, NCT#00225277 Title of Study: A Double-Blind, Randomized, Comparator-Controlled Study in Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl Versus
More informationThe Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6
The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6 n&list_uids=17433949 64-Multislice Detector Computed Tomography Coronary Angiography as Potential Alternative
More informationPROMUS Element Experience In AMC
Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical
More information